![]() Prior to investing into a fund, please read the relevant key information document which contains important information about the fund. Blueprint Medicines Corporation (BPMC) Stock Price, Quote & News - Stock Analysis Blueprint Medicines Corporation () +1.43 (2.52) Jun 2, 2023, 4:00 PM EDT - Market closed 2.52 ( 1D) About BPMC Financial Performance In 2022, BPMCs revenue was 204.04 million, an increase of 13. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. ![]() You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. With two precision therapies already approved, Blueprint is currently working on multiple programs for various cancers. Stock analysis for Blueprint Medicines Corp (BPMC:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. This website does not contain any personal recommendations for a particular course of action, service or product. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. 10:30am AACR: Blueprint wants to make resistance to Tagrisso. Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. Blueprint Medicines Blueprints solid tumor med slapped with partial clinical hold.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |